Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS)

Historical Holders from Q1 2015 to Q1 2025

Symbol
CLLS on Nasdaq
CUSIP
15117K103
Type / Class
Equity / American Depositary Shares, each representing 1 Ordinary Shares
Shares outstanding
100M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
12.8M
Holdings value
$23M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
29
Number of buys
10
Number of sells
-10
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ASTRAZENECA PLC 44% $54.6M 44M AstraZeneca PLC Jan 23, 2025
Bpifrance Participations SA 13.1% $12.8M 10.3M Caisse des Depots Jan 30, 2025
Long Focus Capital Management, LLC 4.6% $5.72M 4.62M LONG FOCUS CAPITAL MANAGEMENT, LLC Dec 31, 2024

Institutional Holders of Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 28K $34.7K -$4 $1.24 2
2024 Q4 12.8M $23M -$367K $1.80 29
2024 Q3 9.77M $20.9M -$17.2K $2.14 27
2024 Q2 9.77M $18.3M +$2.41M $1.87 28
2024 Q1 9.85M $26.1M +$69.3K $2.65 31
2023 Q4 9.82M $30.2M -$3.45M $3.08 33
2023 Q3 11.5M $18.1M -$4.87M $1.58 28
2023 Q2 14M $27.6M -$2.35M $1.97 31
2023 Q1 15.2M $29.3M +$12.4M $1.93 28
2022 Q4 8.73M $18.3M -$3.51M $2.10 36
2022 Q3 10.3M $23.6M -$1.48M $2.29 39
2022 Q2 10.6M $30.1M -$4.7M $2.83 37
2022 Q1 12.3M $55.7M -$33.3M $4.54 45
2021 Q4 15.2M $124M -$18M $8.12 53
2021 Q3 15.4M $194M -$11.5M $12.61 66
2021 Q2 16.2M $250M +$14.5M $15.47 74
2021 Q1 15.2M $308M -$23.9M $20.21 79
2020 Q4 16.2M $438M +$60.9M $27.06 81
2020 Q3 14.2M $263M +$6.61M $18.50 69
2020 Q2 13.9M $246M -$7.13M $17.80 75
2020 Q1 14.4M $132M +$10.4M $9.20 59
2019 Q4 13.2M $226M +$2.24M $17.12 56
2019 Q3 13.1M $136M -$8.88M $10.40 56
2019 Q2 13.3M $208M +$7.74M $15.60 63
2019 Q1 12.7M $232M +$23.9M $18.34 58
2018 Q4 11.5M $191M -$7.77M $16.65 60
2018 Q3 11.1M $313M +$4.92M $28.22 75
2018 Q2 10.9M $308M +$116M $28.29 80
2018 Q1 7.04M $222M -$5.95M $31.51 65
2017 Q4 7.31M $213M +$42.5M $29.15 55
2017 Q3 5.87M $167M +$17.7M $28.45 41
2017 Q2 5.26M $136M -$10.9M $25.82 39
2017 Q1 5.7M $137M +$1.86M $24.00 38
2016 Q4 5.67M $96.1M -$23.1M $16.95 36
2016 Q3 6.64M $160M -$773K $24.08 38
2016 Q2 6.93M $184M +$12.6M $26.59 38
2016 Q1 6.47M $178M -$18.3M $27.50 43
2015 Q4 7.05M $219M +$7.78M $31.03 47
2015 Q3 6.88M $181M +$7.21M $26.36 43
2015 Q2 6.6M $238M +$18.4M $36.08 40
2015 Q1 6.12M $212M +$212M $34.59 44